173 related articles for article (PubMed ID: 3719535)
1. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial.
Hardcastle JD; Armitage NC; Chamberlain J; Amar SS; James PD; Balfour TW
Cancer; 1986 Jul; 58(2):397-403. PubMed ID: 3719535
[TBL] [Abstract][Full Text] [Related]
2. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.
Cummings KM; Michalek A; Mettlin C; Mittelman A
Cancer; 1984 May; 53(10):2201-5. PubMed ID: 6704908
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer--the Nottingham experience.
Armitage NC; Hardcastle JD
Ann Acad Med Singap; 1987 Jul; 16(3):432-6. PubMed ID: 3435009
[TBL] [Abstract][Full Text] [Related]
4. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.
Kewenter J; Björk S; Haglind E; Smith L; Svanvik J; Ahrén C
Cancer; 1988 Aug; 62(3):645-51. PubMed ID: 3292038
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
6. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
7. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.
Kronborg O; Fenger C; Olsen J; Bech K; Søndergaard O
Scand J Gastroenterol; 1989 Jun; 24(5):599-606. PubMed ID: 2762760
[TBL] [Abstract][Full Text] [Related]
8. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.
Kronborg O; Fenger C; Søndergaard O; Pedersen KM; Olsen J
Scand J Gastroenterol; 1987 Aug; 22(6):677-86. PubMed ID: 3659830
[TBL] [Abstract][Full Text] [Related]
9. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
[TBL] [Abstract][Full Text] [Related]
10. [Occult blood screening for colorectal cancer].
Kumanishi Y; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
[TBL] [Abstract][Full Text] [Related]
11. Mass screening for colorectal cancer by testing fecal occult blood.
Fujita M; Nakano Y; Ohta J; Taguchi T
Cancer; 1986 Jun; 57(11):2241-5. PubMed ID: 3697924
[TBL] [Abstract][Full Text] [Related]
12. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
Mandel JS; Church TR; Ederer F; Bond JH
J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
[TBL] [Abstract][Full Text] [Related]
14. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.
Kewenter J; Brevinge H; Engarås B; Haglind E; Ahrén C
Scand J Gastroenterol; 1994 May; 29(5):468-73. PubMed ID: 8036464
[TBL] [Abstract][Full Text] [Related]
15. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
Adamsen S; Kronborg O
Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
[TBL] [Abstract][Full Text] [Related]
16. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an immunochemical test for faecal occult blood in screening for colorectal neoplasia in a high risk group.
Williams JA; Hunter R; Thomas DW; Coles ME; Leong AS; Walsh R; Hoffmann DC; Huber TW; Sen A
Aust N Z J Surg; 1987 Dec; 57(12):951-7. PubMed ID: 3439939
[TBL] [Abstract][Full Text] [Related]
18. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
[TBL] [Abstract][Full Text] [Related]
19. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
20. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
Blom J; Törnberg S
J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
